D. Kankaya Et Al. , "Expression of Caveolin-1 (CAV1), PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence for Prognostic Significance," 99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology , Washington, Kiribati, 2010
Kankaya, D. Et Al. 2010. Expression of Caveolin-1 (CAV1), PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence for Prognostic Significance. 99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology , (Washington, Kiribati).
Kankaya, D., KİREMİTCİ, S., Tulunay, O., & Baltaci, S., (2010). Expression of Caveolin-1 (CAV1), PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence for Prognostic Significance . 99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington, Kiribati
Kankaya, DUYGU Et Al. "Expression of Caveolin-1 (CAV1), PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence for Prognostic Significance," 99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington, Kiribati, 2010
Kankaya, DUYGU Et Al. "Expression of Caveolin-1 (CAV1), PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence for Prognostic Significance." 99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology , Washington, Kiribati, 2010
Kankaya, D. Et Al. (2010) . "Expression of Caveolin-1 (CAV1), PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence for Prognostic Significance." 99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology , Washington, Kiribati.
@conferencepaper{conferencepaper, author={DUYGU ENNELİ Et Al. }, title={Expression of Caveolin-1 (CAV1), PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence for Prognostic Significance}, congress name={99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology}, city={Washington}, country={Kiribati}, year={2010}}